Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY)
2018
Background
This study aimed to investigate whether schedule modification is safe and effective in patients intolerant to the standard eribulin dose and schedule.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
21
References
8
Citations
NaN
KQI